| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Versant Venture Capital Iv, L.P. is a 10% Owner at CRISPR Therapeutics AG. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $83.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 23, 2018 | CRSP Crispr Therapeutics AG | 10% Owner | Sell | 101,994 | $50.68 | $5,168,901.34 | -5.5% |